Advisory

COVID-19 Vaccination Program

Last Updated on 3 months by Publishing Team

2nd March 2022
Public Advisory

Individuals who are currently receiving the first and second dose of the COVID-19 vaccines will be administered with the Pfizer COVID-19 vaccine. The Ministry of Health and Medical Services reminds the public that currently there are no stocks of AstraZeneca vaccine in the country therefore, Pfizer is offered for primary series.

Additionally, both, Pfizer and Moderna COVID-19 vaccines are administered as booster doses to individuals aged 18 years and above. Individuals become eligible for the booster dose 5 months after they have received their 2nd dose.
Eligible individuals are encouraged to get their booster doses to maintain maximum and longer-lasting protection against severe consequences from COVID-19.